ALERT
Very strong study out of Boston raises deep concerns about #COVID19 #vaccines (@pfizer & @moderna_tx )
versus some of the variant #SARSCoV2 mutants. This is a large, exhaustive study. The highlights are:
MOREhttps://www.medrxiv.org/content/10.1101/2021.02.14.21251704v1 …
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
This is...alarming. Thanks for posting.
-
Yes. It means we have a moving target. The current public health steps are good. The ones we will be able to take in 2-3 months, by starting scientific work now, will be better.
End of conversation
New conversation -
-
-
No one is talking about Only one doe anymore Q is whether first dose for all Followed by boost at 12 weeks Would be better as it would Provide baseline 300M single Dose immunity by ca. 1-Jun And two dose by ca. 1-Sept
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
How does that square with this research that the NYTimes said today suggests one dose of Pfizer is robust...? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00448-7/fulltext …
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
This is badly worded, and neutralization titers do not linearly translate into efficacy, but it's an important point: The drop in efficacy from only getting 1 dose versus the full 2 doses is greater for the P.1, P.2, & B.1.351 variants. The bottom line: You must get BOTH doses!
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Vax efficiency is not equivalent to antibody reduction. Jesus, this is straight up misinformation.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.